Academic Detailing Service Resources
Program resources
Inhaled Medicated Devices for COPD Infographic | December 2022
- COPD Infographic | December 2022 [PDF 421 kB]
Acute Pain: Musculoskeletal, Low Back and Post-Surgical | February 2021
- Handout [PDF - 1.8 mB]
- Acute Pain Drug Tables [PDF - 310 kB]
- Acute Pain Conditions and Opioid Prescribing [PDF - 325 kB]
- NSAID Risks [PDF 302 kB]
Hypertension: High Risk, Pregnancy and Children | October 2019
- Handout [PDF - 2.2 mB]
- Calcium and ASA [PDF - 283 kB]
- BP Monitoring and High CV Risk [PDF - 333 kB]
- Summary Statements - Hypertension [PDF 386 kB]
Antibiotics: Why and Why Not | December 2018
- Handout [PDF - 2 mB]
- Antibiotics for Pediatric Patients [PDF - 933 kB]
- Antibiotics for Adults Patients [PDF - 846 kB]
Choices Before Opioids for CNCP | June 2018
- Handout [PDF - 2.5 mB]
- Clinical Pearls [PDF - 374 kB]
- Treatment Considerations [PDF - 325 kB]
- Commonly Used Non-opioids for CNCP [PDF 325 kB]
Program resources - archive
Please note that the program resources below are over three years old and may not reflect the most current evidence available. They are intended only as an archive of the Dalhousie Academic Detailing Service's work.
Epinephrine and Anaphylaxis | October 2017
- Anaphylaxis Management ToolKit [PDF - 712 KB]
- Epinephrine in Anaphylaxis [PDF - 1.6 MB]
- GP Anaphylaxis Handout [PDF - 707 KB]
COPD: What to Do with All These New Inhalers? | March 2017
- Workbook [PDF - 2.5 MB]
- COPD Tips for Therapy (laminate side 1) [PDF - 434 KB]
- Beta 2 Agonist and Muscarinic Antagonist Inahlers (laminate side 2) [PDF - 279 KB]
- Combined Inhalers (laminate side 3) [PDF - 278 KB]
- Inhaler Devices (laminate side 4) [PDF - 265 KB]
Type 2 Diabetes: What After Metformin? | April 2016
- Workbook [PDF - 2MB]
- Type 2 Diabetes: What After Metformin?[PDF - 367 KB]
- Treatment considerations (laminate side 2) [PDF - 304 KB] (updated April 18)
- Costs (laminate side 3) [PDF - 206 KB]
- Current Saftey Data (laminate side 4) [PDF - 214 KB]
Contraception | July 2015
- Workbook [PDF - 3.13 MB]
- Contraception Pearls for Practice (laminate side 1) [PDF - 454 KB]
- Comparison of Products and Prices (laminate side 2) [PDF - 202 KB]
- Products for Acne, Non-hormonal, and Emergency Options (laminate side 3) [PDF - 277 KB]
- Prescribing Pearls (laminate side 4) [PDF - 263 KB]
Oral Anticoagulants in Atrial Fibrillation | November 2014
- Workbook [PDF - 2.01 MB]
- CHA2DS2VASc Risk Criteria and HAS-BLED [PDF - 292 KB]
- Atrial Fibrillation Algorithm [PDF - 218 KB]
- Comparison of DOACs with Warfarin [PDF - 227 KB]
- Clinical Pearls and Weblinks [PDF - 189 KB]
Gout Update | March 2014
- Workbook [PDF - 1.32 MB]
- Summary Sheet [PDF - 270 KB]
- Acute Gout Therapies [PDF - 273 KB]
Lipids in Primary Prevention: A Calcuated Risk | March 2013
- Workbook [PDF - 1.02 MB] | For patients with severe frailty, both primary and secondary prevention are discussed on pages 33 - 41
- Links and Summary [PDF - 97.6 KB]
- Laboratory Testing in Statin Therapy [PDF - 99.2 KB]
Antibiotics: Why and Why Not? | May 2012
- Workbook [PDF - 858 KB]
Issues in Hypertension | July 2011
- Workbook [PDF - 1 MB]
- Evidence for Treatment of Target <140/90 mmHg in the Elderly [PDF - 42.1 KB]
- Evidence for Treatment of Target <130/80 mmHg in Patients with Diabetes [PDF - 37.1 KB]
- Others.
Opiods in Chronic Non-Cancer Pain | October 2010
- Workbook [PDF - 1.02 MB]
- Local Resources for Pain Management [PDF - 79.3 KB]
- Opioid Manager | McMaster University, National Pain Centre
- Costs of Selected Opioids [PDF - 142 KB]
Diabetes: Insulin Analogues & Self-Monitoring | March 2010
- Workbook [PDF - 1.65 MB]
- Insulin Analogues vs. Human Insulins: Summary of COMPUS Findings [PDF - 150 KB]
- Selected Insulins and Costs in NS [PDF - 138 KB]
- COMPUS Recommendations for Self-Monitoring of Blood Glucose (SMBG) [PDF - 63.9 KB]
- Non-Insulin Using Type 2 Diabetes: Decision Tool for SMBG (2010) [PDF - 238 KB] | Diabetes Care Program of Nova Scotia
New Evidence in COPD | March 2009
- Workbook [PDF - 854 KB]
- Diagnosis and Clarification of COPD Severity [PDF - 174 KB]
- Algorithm from 2008 CTS COPD Update: Highlights for Primary Care [PDF - 267 KB]
- What Outcomes will Benefit from Inhalation Therapy? [PDF - 87.2 KB]
- Monitoring and Costs of Therapies [PDF - 228 KB]
Acne Review | September 2008
- Workbook [PDF - 1.31 MB]
- Wholesale Cost of Acne Therapies (not including dispensing fees)
- Suggestions for Treatment [PDF - 80.3 KB]
Proton Pump Inhibitors: Burning Questions | February 2008
- Workbook [PDF - 1.17 MB]
- Algorithms for Management of Dyspepsia and GERD: Comparative Costs [PDF - 253 KB]
- Symptom Relief at Four Weeks in Uninvestigated GERD & Head-to-Head Trials of PPIs in Erosive Esophagitis: Percent of Patients with Healing at Eight Weeks [PDF - 886 KB]
- Case studies [PDF - 139 KB] | Canadian Agency for Drugs and Technology in Health
Type 2 Diabetes: Screening, Prevention, and TZDs | September 2007
- Workbook [PDF - 2.99 MB]
- Key Messages [PDF - 111 KB]
- Screening & Management of High Risk Individuals [PDF - 155 KB]
- Categories of Glycemia in mmol/L [PDF - 137 KB]
- Pre-Diabetes in Canada (ages 40 - 74 years) [PDF - 137 KB] | Public Health Agency of Canada
Additional resources
Clinical significance calculator
- Katie clinical significance calculator | Dalhousie University
If you have any questions or comments please contact:
Kelly MacKinnon at kelly.mackinnon@dal.ca
Dr Edith Baxter at ebaxter@dal.ca
Questions about the clinical significance calculator may also be sent to:
Michelle ten Brinke michelle.tenbrinke@nshealth.ca